Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management
Ibrahim S. Alhomoud(Qassim University), Dave L. Dixon(Joint Commission), Roy Brown(Virginia Commonwealth University), Preethi Chandrasekaran(Southwestern Medical Center), Azita H. Talasaz(NewYork–Presbyterian Hospital), Anurag Mehta(Emory Healthcare)
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
September 1, 2024
Cited by 19
Related Papers
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure
|Journal of Cardiac Failure|2022|406
The Role of Obesity in Type 2 Diabetes Mellitus—An Overview
|International Journal of Molecular Sciences|2024|405
Effects of Probiotics on Gut Microbiota: An Overview
|International Journal of Molecular Sciences|2024|312
2020 ACC/AHA guideline for the management of patients with valvular heart disease
|Journal of Thoracic and Cardiovascular Surgery|2021|251
Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk
|Journal of the American College of Cardiology|2022|154